Neuraxpharm Pharmaceuticals S.L.
9 products tracked · names used in filings: Neuraxpharm Pharmaceuticals S.L.
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Epixram levetiracetam | Application withdrawn | |
| 🇪🇺 | Riulvy tegomil fumarate | Authorised | 2025-07-28 |
| 🇪🇺 | Tuzulby methylphenidate hydrochloride | Authorised | 2025-02-28 |
| 🇪🇺 | Paxneury guanfacine | Authorised | 2025-02-26 |
| 🇪🇺 | Buprenorphine Neuraxpharm buprenorphine | Authorised | 2024-12-19 |
| 🇪🇺 | Dimethyl fumarate Neuraxpharm dimethyl fumarate | Authorised | 2024-04-22 |
| 🇪🇺 | Niapelf paliperidone | Authorised | 2024-03-31 |
| 🇪🇺 | Briumvi ublituximab | Authorised | 2023-05-31 |
| 🇪🇺 | Buccolam midazolam | Authorised | 2011-09-04 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.